Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain
暂无分享,去创建一个
Harumasa Takano | Yasuyuki Kimura | Keisuke Takahata | Hiroshi Ito | Hiroyoshi Takeuchi | Yasuharu Yamamoto | Manabu Kubota | Shin Kurose | Yasunori Sano | Masaru Mimura | Makoto Higuchi | Hiroshi Ito | M. Higuchi | Masaru Mimura | H. Takano | K. Takahata | Yasuyuki Kimura | Yasuharu Yamamoto | H. Takeuchi | M. Kubota | S. Kurose | Yasunori Sano
[1] F. Yasuno,et al. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia. , 2004, The American journal of psychiatry.
[2] J. Kwon,et al. Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study , 2017, Neuropsychopharmacology.
[3] Daniella J. Furman,et al. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release , 2017, Neuropsychopharmacology.
[4] R. Barker,et al. 11C‐PE2I and 18F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study , 2018, Movement disorders : official journal of the Movement Disorder Society.
[5] R. Roth,et al. Autoreceptor Regulation of Dopamine Synthesis , 1990, Annals of the New York Academy of Sciences.
[6] Robert M. Kessler,et al. Midbrain Dopamine Receptor Availability Is Inversely Associated with Novelty-Seeking Traits in Humans , 2008, The Journal of Neuroscience.
[7] L. Reneman,et al. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.
[8] Alain Dagher,et al. Stress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study , 2008, Neuropsychopharmacology.
[9] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[10] H. Nijhout,et al. Passive and active stabilization of dopamine in the striatum , 2009 .
[11] D. Zald,et al. Dopaminergic Network Differences in Human Impulsivity , 2010, Science.
[12] Mattia Veronese,et al. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia , 2017, JAMA psychiatry.
[13] J. Doyon,et al. Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Murray,et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. , 2011, The American journal of psychiatry.
[15] R. Gainetdinov,et al. Dopaminergic Transmission in the Rat Striatum in Vivo in Conditions of Pharmacological Modulation , 2002, Neuroscience and Behavioral Physiology.
[16] C. P. Ford. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission , 2014, Neuroscience.
[17] C. Nemeroff. The Biochemical Basis of Neuropharmacology, 8th ed. , 2004 .
[18] J. Hietala,et al. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. , 2000, The American journal of psychiatry.
[19] Marie-Claude Asselin,et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. , 2009, Archives of general psychiatry.
[20] Harumasa Takano,et al. Regional dopamine synthesis in patients with schizophrenia using L-[β-11C]DOPA PET , 2009, Schizophrenia Research.
[21] T. Woodward,et al. Dopamine, cognitive biases and assessment of certainty: A neurocognitive model of delusions. , 2017, Clinical psychology review.
[22] H. Nijhout,et al. Theoretical Biology and Medical Modelling Open Access Homeostatic Mechanisms in Dopamine Synthesis and Release: a Mathematical Model , 2022 .
[23] V. Sossi,et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.
[24] J. Hietala,et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients , 1995, The Lancet.
[25] C. Halldin,et al. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[&bgr;-11C]DOPA and [18F]FE-PE2I in humans , 2014, Nuclear medicine communications.
[26] N. Kawashima,et al. Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug , 2012, Annals of General Psychiatry.
[27] V. Shahrezaei,et al. Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance , 2020, Biological Psychiatry.
[28] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] Yen F. Tai,et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.
[30] Harumasa Takano,et al. Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. , 2009, Journal of psychiatric research.
[31] B. Långström,et al. Brain kinetics of L-[Β-11 C]DOPA in humans studied by positron emission tomography , 2005, Journal of Neural Transmission / General Section JNT.
[32] Hidehiko Takahashi,et al. Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA , 2012, PloS one.
[33] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] K. Lewandowski,et al. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions. , 2007, Harvard review of psychiatry.
[35] S. Houle,et al. Influence of l-dopa and pramipexole on striatal dopamine transporter in early PD , 2001, Neurology.
[36] Hidehiko Takahashi,et al. Effects of the Antipsychotic Risperidone on Dopamine Synthesis in Human Brain Measured by Positron Emission Tomography with l-[β-11C]DOPA: A Stabilizing Effect for Dopaminergic Neurotransmission? , 2009, The Journal of Neuroscience.
[37] A. Heinz,et al. Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[38] Andrea Anzalone,et al. Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors , 2012, The Journal of Neuroscience.
[39] Paul Cumming,et al. The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males , 2013, The Journal of Neuroscience.
[40] F. Mottaghy,et al. Acute and Sustained Effects of Methylphenidate on Cognition and Presynaptic Dopamine Metabolism: An [18F]FDOPA PET Study , 2014, The Journal of Neuroscience.
[41] L. Mucke,et al. A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.
[42] B. Långström,et al. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography , 2005, Journal of Neural Transmission.
[43] Federico Turkheimer,et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. , 2013, Brain : a journal of neurology.
[44] J. Delay,et al. [Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)]. , 1952, Annales medico-psychologiques.
[45] A. Grace. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression , 2016, Nature Reviews Neuroscience.
[46] D. Siskind,et al. Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[47] J. Lieberman,et al. Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.
[48] Tobias U. Hauser,et al. Endogenous fluctuations in the dopaminergic midbrain drive behavioral choice variability , 2019, Proceedings of the National Academy of Sciences.
[49] R. Murray,et al. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. , 2012, The American journal of psychiatry.
[50] L. Vanderschuren,et al. Critical Involvement of Dopaminergic Neurotransmission in Impulsive Decision Making , 2006, Biological Psychiatry.
[51] F. Bloom,et al. The Biochemical Basis of Neuropharmacology , 1976 .
[52] J. Wickens,et al. Role of homeostatic feedback mechanisms in modulating methylphenidate actions on phasic dopamine signaling in the striatum of awake behaving rats , 2019, Progress in Neurobiology.
[53] P. Garris,et al. Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals , 1997, Brain Research.
[54] K. Blum,et al. Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. , 2017, Frontiers in bioscience.
[55] J. Ferreira,et al. The gut–brain dopamine axis: A regulatory system for caloric intake , 2012, Physiology & Behavior.
[56] Fumitoshi Kodaka,et al. Relation between Presynaptic and Postsynaptic Dopaminergic Functions Measured by Positron Emission Tomography: Implication of Dopaminergic Tone , 2011, The Journal of Neuroscience.
[57] A. Patiño-García,et al. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment , 2007, The Pharmacogenomics Journal.
[58] A. Egerton,et al. Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort , 2013, Biological Psychiatry.
[59] J. Pavía,et al. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism , 2005, Psychopharmacology.
[60] V L KOZLOWSKI,et al. Depressive symptoms. , 1959, Medical times.
[61] A. Grace,et al. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.
[62] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[63] Abraham Weizman,et al. Increased platelet vesicular monoamine transporter density in adult schizophrenia patients , 2002, European Neuropsychopharmacology.
[64] J. Hietala,et al. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia , 1999, Schizophrenia Research.
[65] Alan A. Wilson,et al. Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.
[66] S. Aoki,et al. Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT , 2017, Annals of Nuclear Medicine.
[67] R. Wightman,et al. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis 1 Published on the World Wide Web on 27 January 1998. 1 , 1998, Brain Research Reviews.
[68] R. Wightman,et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Murray,et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study , 2011, Molecular Psychiatry.
[70] F. Mottaghy,et al. The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia , 2018, Psychopharmacology.
[71] M. Grégoire,et al. Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-Dopa , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] O. Hikosaka,et al. Differential roles of monkey striatum in learning of sequential hand movement , 1997, Experimental Brain Research.
[73] A. Salgado,et al. Unilateral accumbal dopamine depletion affects decision-making in a side-specific manner , 2020, Experimental Neurology.
[74] Paul Cumming,et al. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. , 2005, The American journal of psychiatry.